FTC nominees vow to take on drug pricing

Charles McConnell

15 February 2018

Nominees to fill three commissioner vacancies and replace the acting chairman of the Federal Trade Commission have unanimously said they would make drug pricing a top priority upon being confirmed.

Subscribe to Global Competition Review

Subscribe and start reading now

Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.

Subscribe now

Already have access? Login below

Charles McConnell

View full biography

Author | Senior reporter, Global Competition Review

[email protected]

Get unlimited access to all Global Competition Review content